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Abstract 
The importance of aspartic proteinases in human pathophysiology continues to initiate extensive research. With burgeoning information on their 
biological functions and structures, the traditional view of the role of activation peptides of aspartic proteinases olely as inhibitors of the active site 
is changing. These peptide segments, or pro-parts, am deemed important for correct folding, targeting, and control of the activation of aspartic 
proteinase zymogens. Consequently, the primary structures of pro-parts reflect these functions. We discuss guidelines for formation of hypotheses 
derived from comparing the physiological function of aspartic proteinases and sequences of their pro-parts. 
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1. Introduction 
Aspartic proteinases (EC 3.4.23) share a high degree 
of similarity which involves primary structures, extend- 
ing through almost identical secondary structural motifs 
and manifesting a typical bilobal molecular shape [1,2]. 
Despite this overall similarity, substantial differences 
exist in the catalytic properties, the cellular localization, 
and cons~uently the biological function of this family 
of enzymes. Aspartic proteinases are usually divided into 
the following groups : pepsins and chymosins, cathep- 
sins, renins, fungal aspartic proteinases and retroviral 
aspartic proteinases [3]. Eucaryotic aspartic proteinases 
are usually bilobal, monomeric molecules, while retrovi- 
ral proteinases are functional as dimers of identical poly- 
peptides [4]. Available evidence suggests that all eucar- 
yotic aspartic proteinases are synthesized as zymogens. 
Retroviral aspartic proteinases, on the other hand, are 
synthesized as a part of a structural polyprotein [S]. In 
our review we focus on the roles of activation peptides, 
also referred to as pro-parts, in the function of aspartic 
proteinases. The p~icipation of these peptides in the 
auto-activation of aspartic proteinases has been reviewed 
[6,7]. Several new features have been recognized for the 
function of pro-parts and are highlighted in our review 
of recent work. 
The processing of newly synthesized aspartic pro- 
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teinases tarts with the removal of their signal peptides 
during the passage into the endoplasmic reticulum. The 
complete activation of eucaryotic zymogens of aspartic 
proteinases is accomplished by a proteolytic removal of 
the N-terminal pro-part which is usually 44-50 amino 
acids long [6,7]. The known sequences of pro-parts of 
aspartic proteinases are summarized in the legend to Fig. 
1. Numerous three-dimensional structures of activated 
aspartic proteinases are known f2,3] but for their zymo- 
gens only the tertiary structure of pig pepsinogen A is 
available [8,9] and preliminary data on the human 
progastricsin structure were recently reported by James 
et al. [lo]. 
Recent evidence suggests that the pro-parts of aspartic 
proteinases participate in folding and in cellular sorting 
events. Furthermore, their sequences reveal conserved 
motifs correlated to the pH of physiological activation 
and to the mode of activation. Our review is organized 
accordingly. 
2. Foldiug of zytnogens 
The pro-part of yeast proteinase A of Saccharomycq 
cerevisiae was shown to function as an intramolecular 
chaperon during the folding of the zymogen in vivo 
[11,12]. These studies suggest that the chaperon-like 
function depends on the N-terminal portion of the pro- 
part. Indirect evidence for such a function of pro-parts 
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of aspartic proteinases follows from experiments on the 
expression of human procathepsin D in mammalian cells 
[13]. When this enzyme was expressed without the pro- 
1P 1OP 2OP 3OP 
PIGPEPA ........ ..LVKVPLVRK.KSLRQNLIK.NhK...LKDF.LKTHKHN .. 
HUMPEPA ....... ..IMYKVPLIRK.KSLRRTL.SERGL...LKDF.LKKHNLN .. 
TUNPEPA ........ ..LIQVPL.EKGQSAREYL.QEQGL...WEQYRLK.YPYN .. 
CHIPEPA ....... ..SIHRVPL.KKGKSLRKQL.KDHGL...LEDF.LKKHPYN .. 
BOVPEPB ........ ..LVKIPL.KKFKSIREIM.KEKGL...LZBF.LRTYKHN .. 
HUNPEPC ...... ..AAWKVPL.KKFKSIRETM.KEKGL...LGEF.LRTHKYD .. 
GPGPEPC ....... ..TQIKVPL.KKIKSIREVL.REKGL...LGDF.LKNHKPQ .. 
BOVCHY ...... ..AEITRIPL.YKGKSLRKAL.KEHGL...LEDF.LQKQQYG .. 
OVICHY ...... ..AEITRIPL.YKGKPLRKAL.KERGL...LEDF.LQKQQYG .. 
HUNREN TFGLPTDTTTFKRIFL.KRMPSIRESL.KERGV..DMARLG...PEWS .. 
MOUREN TFSLPTRTATFERIPL.KKNPSVREIL.EERGV..DMTRLS...AERG .. 
HUMCE ..... ..QGSLtfRVPL.RRHPSLKKKL.RARSQ...ISEF.WKSHNLD .. 
GPGCE ....... ..ALHRVPLSRR.ESLRKKL.RAQGQ...LTEL.WKSQNLN .. 
HUMCD .......... LVRIPL.HKFTSIRRTMSEVGGSV...EDL.IA..K.G .. 
INSCD ....... ..DFVRVQL.HKTESARQHF........RNVDTEIKQ ...... 
CELCD ........ ..IQRIKLEKR......TYTRE......QYKFGSIQ.EH ... 
PEP4 ......... ..AKV...HK...AKIYKHELSD.EMKEVTFEQH.LAH ... 
BARP ...... ..EGLVRIALKKR..PIDRN.SRVATGLSGGEEQPL..LSGAN. 
EPAP ALSSPTKQHVGIPVNASPEVGPGKYSFKQVRNPNYKFNG.PL.SV.KKTY 
MPAP ....... ..LTSRRPV ......... S.KQ.SDADDKLLALPLTSVNR ... 
CAAP .................. ..TPT..TTKR...SAG.FVALDFSW.KTP. 
YAP3 .......... KIIPAANKRDDDSNSKFVKLPFHKLYGDSLENVGSDKKPE 
4OP 
l * . 
PIGPEPA . 
HUNPEPA .cz%zz:::~~::::::::::::::::~kzz~ 
TUNPEPA .PMAKF........DPSFAVA...............GEPMTN D 
CHIPEPA .PASKYHPV.I&.TESY...................EPMTN Y 
BOVPEPB .PAEKY...RF....GDFIVAT...............EPMD .Y 
HUNPEPC .PAWKY...RF....G D ............. ..EPMA .Y 
GPGPEPC .HARKFFRNRLAK.TGD r j LY...............EPMS .Y 
BOVCHY .ISSKY.SG. 
$ 
.VASV....................PLTN Y 
OVICHY .VSSEY.SG. .E.VASV....................PLTN Y 
..LGNTTSSVI....................LTN Y 
MOUREN .V LINLTSPW....................tiTN Y 
HIJNCE .. FTE.SCSMD..............QSAKEPLIN Y 
... ..CST I ............ ..QSANEPLIN Y 
HUMCD .PVSKY.SQ.......AV..........PAVTE@PIPEVLKN Y 
INSCD .LRLKYN......................AVS.dPVPEPLSN Y 
CELCD .LKAKYVPGYIPN.KD.............AFNEG ..... LSDY 
PEP4 .LGQKYLTQFEKA..NPE.WFSREH...PFFTEgGHDVPLTN Y 
BARP .P.LR..f$E......................EEGDIVA.LKN Y 
EPAP ... LKY.GVPIPAWLEDAVQNSTSGLAERS@G.SATTTPIDSL 
MPAP .... KYSQTK.HGQQAAEKI.GGIKAF@E.GDG.S.VDTP.GLY 
CAAP .... KAF..PVTN..GQEGKTS.KR....gAVPVTLHNEQVT Y 
YAP3 VRLLKR&x?Y.....................EEIIITNQQSF Y 
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part, it was rapidly degraded intracellularly, probably as 
a result of improper folding. However, a different situa- 
tion exists for renin where the enzyme expressed without 
the pro-part was correctly folded [14]. Successful folding 
of synthetic mature retroviral proteinases implies that no 
pro-part is, in this case, necessary for the folding step 
[ 151. Accordingly, evidence of Lin et al. [ 161 indicates that 
the C-terminal domain of porcine pepsin may fold inde- 
pendently of the pro-part, although the N-terminal do- 
main expressed without the pro-part folds poorly. These 
findings suggest hat for some eucaryotic aspartic pro- 
teinase zymogens the pro-part may have co-evolved with 
the N-terminal domain following a gene-duplication 
event [l] in order to facilitate folding of this more re- 
cently specialized domain. 
Similar observations of the dependence of folding 
upon the pro-part were made for the family of serine 
proteinases where an alternating pattern between 
charged and hydrophobic residues within pro-parts was 
suggested to play an important role in the intramolecu- 
lar-chaperon function [ 171. 
3. Sorting of aspartic proteinases 
Aspartic proteinases function both extracellularly and 
intracellularly. Pepsins are secreted from specialized 
stomach chief cells after a signal transmitted by the 
hormone gastrin, whereas the secretion of prorenin is 
controlled by many renal factors, and an unknown signal 
initiates the secretion of fungal proteinases. Yeast and 
Fig. 1. Multiple sequence alignment of activation peptides of aspartic proteinases. Each sequence includes the activation peptide plus subsequent 
amino acids of the mature amino terminus including the residue which aligns with Tyr9 of porcine pepsinogen (PIGPEPA). The numbering is 
according to PIGPEPA. Mature amino termini are shaded; the positions of the Lys36P, Tyr37P, and Tyr9 of PIGPEPA are marked with an * above 
their positions. The Lys36P, Tyr37P, Tyr9 triad interacts with the active site in the pepsinogen crystal strcuture [8,9]. Vertebrate sequences were aligned 
first using GCG PILEUP [45] with minor alterations made to the alignment. Remaining fungal sequences were aligned to that group. The sequences 
were obtained from either GENBANK (GB), EMBL (EM), PIR, or SWISSPROT (SW) data banks using GCG TFASTA or FASTA with the 
N-terminal 77 amino acids of human cathepsin D as a query sequence. Sequences are listed with species, proteinase name, keyword as appears in 
the alignment, and databank accession number. Appearing in the aligmnent are: Porcine pepsin A, PIGPEPA, PIR:A32455; Human pepsin A, 
HUMPEPA, PIR:A00980; Tuna pepsin 1, TUNPEPA, SWP20139; Chicken pepsin A, CHIPEPA, PIR:AOO984; Bovine pepsin B, BOVPEPB, 
PIRA23457; Human pepsin C, HUMPEPC, PIR:A31811; Guniea pig pepsin C, GPGPEPC, PIRB43356; Bovine chymosin A, BOVCHY, 
PIR:A00985; Ovine chymosin, OVJCHY, PIR:S10996; Human renin, HUMREN, PIR:A21454; Mouse renin, MOUREN, PIR:JHOO83; Human 
cathepsin E, HUMCE, PIR:A34401; Guinea pig cathepsin E, GPGCE, PIR:A43356; Human cathepsin D, HUMCD, PIR:A25771; Mosquito aspartic 
proteinase, INSCD, GB:A45117; C. eleguns clone homologous to cathepsin D, CELCD, GB:M88822; S. cerevisiae proteinase A, PEP4, PIR:A25379; 
Barley aspartic proteinase, BARP, PIR:S19697; E. parasitica endothiapepsin, EPAP, PIR:S26871; M. pusilhu aspartic proteinase, MPAP, 
PIRzA25167; C. albicans aspartic proteinase, CAAP, SWPS8871; S. cerevisiae aspartic proteinase, YAP3, PIR:S20150. Other sequences obtained 
from the databank search, but not included in the alignment are listed here as above: Bear pepsin A, PIRA28859; Bovine pepsin A, PIR:A92157; 
C. degans clone homologous to pepsin, GB:M89231; Embryonic chicken pepsin A, PIR:A41443; Rhesus macaque pepsin A, PIRJT0309; Japanese 
macaque pepsin A, PIR:S1968 1; Rabbit pepsin A, PIR:B38302; Rabbit pepsin F, PIR:A38302; Rat pepsin A, PIR:A24608; Tuna pepsin 2, SWP20140; 
Bullfrog pepsin C, PIR:A39314; Japanese macaque pepsin C, PIR:AOO986; Rat pepsin C, PIR:A05145; Bovine cathepsin D, SWP80209; Chicken 
cathepsin D, GB:S49650; Mouse cathepsin D, PIR:S14704; Rat cathepsin D, PIR:S13111; Rat renin, PIRA29991; Rat cathepsin E, PIR:A34657; 
S. aureus cathepsin E, PIR:C34643; Feline chymosin, PIR:A20146; Human chymosin pseudogene, GB:M57258 (exon 1 of 9); A. awamori aspergil- 
lopepsin A, PIR:PS0140; C. albicans intracellular aspartic proteinase, SWP10977; C. parapsilosis aspartic proteinase 1, GB:Zll919; C. parapsilosis 
aspartic proteinase 2, GB:Z11918; C. tropicalis aspartic proteinase, SWQ00663; M. miehei aspartic proteinase, PIR:A29039; R chinensis rhizopus- 
pepsin, GB:M63451;R. niveus aspartic proteinase I, GB:M19100; R. nivew aspartic proteinase II, GB:X56964; R niveus aspartic proteinase III, 
PIR:JU0343; R. niveus aspartic proteinase IV, GB:X56992; R niveus aspartic proteinase V, GB:X56993; S. cerevisiae barrier protein, PIR:A34084; 
S. jibulgeria acid proteinase, PEPI, PIRJT0334; Bovine aspartic proteinase, PIRJT0399; Bovine pregnancy-specific antigen, PIR:B41545; Ovine 
pregnancy-specific antigen, PIR:A41545; Rice aspartic proteinase, PIR:JS0732. 
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Fig. 2. Hydrogen bond interactions (dashed lines) of active site aspartic 
acids 32 and 215 with Lys36P, Tyr37P, and Tyr9 of porcine pep- 
sinogen [9]. 
mammalian proteinases with prohormone processing ac- 
tivity were suggested to be localized within secretory 
vesicles [18,19]. Human cathepsin D is localized in lyso- 
somes (reviewed by Hasilik, [20]) and yeast proteinase A 
is localized in vacuoles (vacuoles in yeast are equivalent 
to lysosomes) [21] and both are major intracellular as- 
partic proteinases, while cathepsin E is localized intracel- 
lularly but extra-lysosomally [22]. 
Human cathepsin D is targeted to lysosomes by the 
mannose-6-phosphate (M6P) targeting pathway using 
the M6P marker and also by an alternative targeting 
pathway (reviewed by Kornfeld and Mellman, [23]). 
There are several reports on M6P-independent associa- 
tion of procathepsin D with intracellular membranes of 
mammalian cells (summarized in [25]), suggesting inter- 
action of the pro-part with yet unknown receptor(s). A 
60 kDa protein specifically interacting with procathepsin 
D within the cell has been identified which may be the 
receptor [26]. It was recently shown that rat procathepsin 
D, expressed in yeast, is correctly targeted to the acidic 
vacuoles suggesting an interaction with the same target- 
ing system as the zymogen of proteinase A [24]. In yeast, 
the C-terminal part of the pro-part of proteinase A seems 
to play a crucial role in the targeting of the zymogen to 
vacuoles [ 111. 
The alignment shown in Fig. 1 indicates a similarity 
between part of the pro-part of proteinase A and the 
pro-parts of procathepsin D molecules (sequence Pro- 
Ala-Val-Thr-Glu-Gly, at the C-terminus of procathepsin 
D pro-part). A three-dimensional model of human pro- 
cathepsin D suggests that this region of procathepsin D 
may form a surface exposed structure [27]. We propose 
that this sequence might be an evolutionarily related 
region between pro-parts of proteinase A and procathep- 
sin D which can interact with a receptor. This hypothesis 
has recently been supported by the identification of a 
sequence of the pro-part of procathepsin L which inter- 
acts with an intracellular receptor [28]. Similarity be- 
tween the sequences of non-homologous lysosomal and 
vacuolar proteins procathepsin L and yeast procar- 
boxypeptidase Y was also identified [28]. 
4. Mode of processing 
The activation of zymogens of aspartic proteinases is 
presumably initiated by a dramatic conformational re- 
arrangement of the first 60 amino acids of the zymogen 
[8,9]. This process is often triggered by low pH and re- 
sults in proteolytic cleavage of a pro-part [6,7]. 
The following three mechanisms have been observed 
for the degree to which zymogens of aspartic proteinases 
may undergo self-processing of their pro-parts during 
activation: complete self-processing, self-processing 
which is partially assisted by a different proteinase, or 
fully assisted processing. An example of the first type is 
stomach pepsinogens A (reviewed by Tang, [6]) for which 
both intramolecular and intermolecular autoactivation 
may contribute to the activation of these zymogens [29]. 
Lysosomal and vacuolar proteinases are representatives 
of the second type. Human procathepsin D is capable of 
only partial self processing and activation [30,31] requir- 
ing lysosomal cysteine proteinase(s) for the final process- 
ing of its pro-part [32]. Similarly, serine vacuolar pro- 
teinase B is responsible for the final proteolytic matura- 
tion of the zymogen of proteinase A of yeast [33]. The 
third type of processing of the pro-part is typical for the 
activation of prorenin. Either thiol [34] or serine pro- 
teinase [35] was shown to be required in this process, 
depending on the source of the prorenin. 
The activation of retroviral aspartic proteinases is 
more complicated as most are synthesized as a subunit 
of gag-pol derived polyprotein precursors with resulting 
N- and C-terminal extensions [5]. Autoprocessing of the 
precursor of HIV proteinase was demonstrated with a 
shortened form of the precursor [36]. The N-terminal, p6 
peptide extension of HIV proteinase is involved in the 
inhibitory regulation of proteinase autoprocessing remi- 
niscent of the function of pro-parts [371. Constructs of 
HIV aspartic proteinase with partial N-terminal exten- 
sions with an introduced mutation which prevented the 
self-cleavage of the proteinase were found as intrinsically 
active and displayed a pH-optimum shift to neutral pH 
[38]. Possible roles of these terminal extensions in the 
viral replication process remains to be elucidated. 
A prediction of the type of processing of proenzymes 
of aspartic proteinases might be sought from their pri- 
mary structures (Fig. 1). It is reasonable to propose that 
for zymogens which are capable of self-activation, the 
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cleavage site at their mature termini should be in agree- 
ment with their specificity. The two hydrophobic resi- 
dues, preferred at P, and P1’ positions by pepsins [39], are 
found in the cleavage sites of the zymogen. On the con- 
trary, cathepsin D, which shares analogous general spec- 
ificity, has the sequence Glu-Gly as the Ihral assisted 
maturation cleavage site. A similar feature is found in 
other aspartic proteinases; for example renin or pro- 
teinase A for which activation is assisted by different 
processing enzymes. 
The data on aspartic proteinases with only partially 
processed pro-parts indicate that these forms might have 
different biological properties compared to fully acti- 
vated enzymes. The importance of these forms remains 
to be elucidated. 
5. The pH of physiological activation 
Intact pro-parts of human procathepsin D and 
chicken pepsinogen inhibit most aspartic proteinases 
with hi in the nanomolar range and with significant pH 
dependence [40]. Screening of synthetic fragments of the 
pro-part of prorenin identified two shorter peptides in- 
hibiting renin: the peptide lOP-20P and the C-terminal 
peptide 32P-43P [41]. It was also shown that N-terminal 
fragments of the pro-part of pig pepsinogen (lP-12P and 
lP-16P) are inhibitory [29,42]. The sequence alignment 
of prorenin and pepsinogen shows similarity between 
region 5P-15P of pig pepsinogen and lop-20 of human 
prorenin (Fig. 1) which, together with the inhibition 
data, may reflect similarity in function. 
The fact that two independent motifs within the pro- 
parts are inhibitory can be explained from the X-ray 
structure of pig pepsinogen. The N-terminal portion 
(lP-9P) of the pro-part participates in a beta-sheet and 
interacts with residues of the S, binding subsite [2] while 
the structure of the doublet Lys36P-Tyr37P and the 
highly conserved hydrophobic residue Tyr9 forms hy- 
drogen bonds with the active site aspartates blocking S, 
and S,’ subsites (Fig. 2). Inhibition of aspartic pro- 
teinases by these two segments of the pro-part may be 
explained by interactions seen in the native zymogen 
structure. As both of these regions contain titrable resi- 
dues it is plausible that their ionization states contribute 
to the inhibitory function optimally at pH for which 
ionic interactions may be maintained [8,9]. 
At low pH, protonation of acidic amino acids involved 
in ionic interactions of the pro-part is proposed to trigger 
the conformational change which is followed by the 
cleavage of the pro-part [7]. An interesting coincidence 
is found when zymogens of aspartic proteinases are 
grouped according to the pH of their physiological com- 
partmentation and according to the presence of the 
Lys36P-Tyr37P sequence (Fig. 1). Those proteinases 
which are activated at lower pH (pepsin, cathepsin D, 
yeast vacuolar proteinase A) apparently have the Lys- 
Tyr mechanism for locking the active site. On the other 
hand, those proteinases which are activated at higher pH 
(renin, cathepsin E, Candida yeast extracellular aspartic 
proteinases) evidently employ a different device for 
blocking and/or protection of the active site. There are 
reports on the detection of proteolytic activity of intact 
pro-renin (summarized in [43]), which supports the idea 
that the presence of the Lys-Tyr pair in the primary 
structure of the pro-part influences the pH of physiolog- 
ical activation. 
6. Conclusions 
The pro-parts of zymogens of aspartic proteinases 
have multiple functions. Some of these functions have a 
plausible explanation based on a multiple sequence 
alignment and on the tertiary structure of porcine pep- 
sinogen and three conclusions can be made. First, the 
presence or absence of the Lys-Tyr sequence in the pro- 
part can be used as an indicator of pH of physiological 
activation when only the sequence of a zymogen is 
known. Second, the sequence near the maturation cleav- 
age site (Pro-Ala-Val-Thr-Glu-Gly in procathepsin D) 
seems to be a potential candidate for the interactions of 
some aspartic proteinases with cellular receptors for tar- 
geting. Third, a sequence of the maturation cleavage site 
which is not in agreement with the specificity of that 
particular proteinase indicates control of the maturation 
process by the action of a different proteinase. The na- 
ture of multiple roles for pro-parts of aspartic proteinase 
zymogens described here is probably a more general fea- 
ture common also to pro-parts of other classes of prote- 
olytic enzymes [44]. 
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